Bio Medica Laboratories Limited logo

IPO details · Updated

Bio Medica Laboratories Limited

ClosedSMENSE: BMLL
Check Allotment
Price Band
₹132 – ₹139
Lot Size
1,000 shares
Min. Investment
₹1,39,000
Issue Size
₹52.43 Cr
Offer Dates
21 May – 25 May 2026
Listing
29 May 2026

Issue Details

Full details →
Total Issue Size
₹52.43 Cr
37,72,000 shares
Fresh Issue
₹47.19 Cr
33,95,000 shares
Offer for Sale
₹5.24 Cr
3,77,000 shares
Face Value
₹10 per share
Issue Type
Book-built IPO
Listing At
NSE SME
Shares Pre-Issue
91,80,001
Shares Post-Issue
1,25,75,001

IPO Timeline

  1. Offer opens

    21 May 2026

  2. Offer closes

    25 May 2026

  3. Allotment

    26 May 2026

  4. Listing

    29 May 2026

Issue Allocation

Share of the offer reserved for each investor category

  • QIB1.0%36,000 shares
  • HNI46.5%17,55,000 shares
  • Retail47.5%17,92,000 shares
  • MarketMaker5.0%1,89,000 shares

Subscription Status

Times subscribed by investor category

CategoryOfferedBidsSubscribed
QIB36,0005,73,840
15.94x
NII17,55,00022,81,500
1.30x
Retail17,92,00052,32,640
2.92x
Total35,83,00080,87,980
2.26x

Lot Size & Investment

1 lot = 1,000 shares

Retail (min)

2 lots · 2,000 shares

Retail (max)

2 lots · 2,000 shares

S-HNI (min)

3 lots · 3,000 shares

ApplicationLotsSharesAmount
Retail22,000₹2,78,000
Small HNI (S-HNI)33,000₹4,17,000
Big HNI (B-HNI)88,000₹11,12,000

Financial Performance

Restated figures in ₹ crore, unless stated otherwise

Financial performance by period
PeriodNov-25Mar-25Mar-24Mar-23
Assets65.1739.1219.5317.57
Total Income28.6338.3315.3416.25
Profit After Tax8.669.792.50.33
EBITDA13.4515.215.631.7
Net Worth17.1214.734.942.44
Reserves & Surplus7.945.554.842.34
Total Borrowing38.1715.0110.499.61

Key Performance Indicators

Key performance indicators
PeriodNov-25Mar-25
ROE (%)54.4199.59
ROCE (%)23.2248.2
EPS (₹)10.67
P/E (pre-issue)13.03
P/E (post-issue)13.45

Peer Comparison

Listed companies in the same business

CompanyP/EROE
Zenotech Laboratories Limited6.01%
Shukra Pharmaceuticals Limited47.5715.9%

About Bio Medica Laboratories Limited

Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in liquid and dry-powder injectable forms.der injectables. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare. Product portfolio: Liquid Injectables: 58 products are offered under this category Dry powder injectables: 15 products under this category It offers comprehensive range of products, including generic drugs, branded pharmaceuticals, over the counter (OTC) products, and other medications. The company operates on a B2B model, focusing exclusively on contract manufacturing. It develop formulations for various companies in accordance with their specific requirements and product specifications. It is certified for Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certificate issued by the Food & Drugs Administration, Madhya Pradesh. It has two manufacturing facilities in Indore, Madhya Pradesh. Competitive Strengths Multi-product capability and diversified product portfolio Experienced promoters, management and employees. Quality assurance Established client relationship

Objects of the Issue

  • Repayment of loan (₹6.50 Cr)
  • Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises (₹28.50 Cr)
  • General Corporate Purposes (₹7.05 Cr)
  • Issue Expense (₹5.14 Cr)

Promoters

  • Mukesh Mehta
  • Pradeep Mehta

Company Information

Book running lead managers
  • Narnolia Financial Services Ltd.
Registered office
Plot No.11B-11C, Sector-E, Sanwer Road, Industrial Area, Industrial Estate, Indore, Madhya Pradesh, 452015
Market maker
Prabhat Financial Services Ltd.

Official Documents

Opens the source filing in a new tab

Disclaimer: Data on OpenIPO is for information only and is not investment advice. OpenIPO is not a SEBI-registered entity. GMP figures are unofficial estimates and may change. Verify all details against the company RHP and the official registrar before investing.